BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 24185511)

  • 1. Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.
    Francis JM; Kiezun A; Ramos AH; Serra S; Pedamallu CS; Qian ZR; Banck MS; Kanwar R; Kulkarni AA; Karpathakis A; Manzo V; Contractor T; Philips J; Nickerson E; Pho N; Hooshmand SM; Brais LK; Lawrence MS; Pugh T; McKenna A; Sivachenko A; Cibulskis K; Carter SL; Ojesina AI; Freeman S; Jones RT; Voet D; Saksena G; Auclair D; Onofrio R; Shefler E; Sougnez C; Grimsby J; Green L; Lennon N; Meyer T; Caplin M; Chung DC; Beutler AS; Ogino S; Thirlwell C; Shivdasani R; Asa SL; Harris CR; Getz G; Kulke M; Meyerson M
    Nat Genet; 2013 Dec; 45(12):1483-6. PubMed ID: 24185511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors.
    Crona J; Gustavsson T; Norlén O; Edfeldt K; Åkerström T; Westin G; Hellman P; Björklund P; Stålberg P
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1428-35. PubMed ID: 25586243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Driver mutations occur frequently in metastases of well-differentiated small intestine neuroendocrine tumours.
    Samsom KG; Levy S; van Veenendaal LM; Roepman P; Kodach LL; Steeghs N; Valk GD; Wouter Dercksen M; Kuhlmann KFD; Verbeek WHM; Meijer GA; Tesselaar MET; van den Berg JG
    Histopathology; 2021 Mar; 78(4):556-566. PubMed ID: 32931025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.
    Viotto D; Russo F; Anania I; Segatto I; Rampioni Vinciguerra GL; Dall'Acqua A; Bomben R; Perin T; Cusan M; Schiappacassi M; Gerratana L; D'Andrea S; Citron F; Vit F; Musco L; Mattevi MC; Mungo G; Nicoloso MS; Sonego M; Massarut S; Sorio R; Barzan L; Franchin G; Giorda G; Lucia E; Sulfaro S; Giacomarra V; Polesel J; Toffolutti F; Canzonieri V; Puglisi F; Gattei V; Vecchione A; Belletti B; Baldassarre G
    J Pathol; 2021 Feb; 253(2):234-245. PubMed ID: 33140857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors.
    Hofving T; Elias E; Rehammar A; Inge L; Altiparmak G; Persson M; Kristiansson E; Johansson ME; Nilsson O; Arvidsson Y
    BMC Cancer; 2021 Jan; 21(1):101. PubMed ID: 33509126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor.
    Karpathakis A; Dibra H; Pipinikas C; Feber A; Morris T; Francis J; Oukrif D; Mandair D; Pericleous M; Mohmaduvesh M; Serra S; Ogunbiyi O; Novelli M; Luong T; Asa SL; Kulke M; Toumpanakis C; Meyer T; Caplin M; Meyerson M; Beck S; Thirlwell C
    Clin Cancer Res; 2016 Jan; 22(1):250-8. PubMed ID: 26169971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exome Sequencing and CNV Analysis on Chromosome 18 in Small Intestinal Neuroendocrine Tumors: Ruling Out a Suspect?
    Delgado Verdugo A; Crona J; Maharjan R; Hellman P; Westin G; Björklund P
    Horm Metab Res; 2015 Jun; 47(6):452-5. PubMed ID: 25354328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a heritable contribution to neuroendocrine tumors of the small intestine.
    Neklason DW; VanDerslice J; Curtin K; Cannon-Albright LA
    Endocr Relat Cancer; 2016 Feb; 23(2):93-100. PubMed ID: 26604321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics and epigenetics in small intestinal neuroendocrine tumours.
    Stålberg P; Westin G; Thirlwell C
    J Intern Med; 2016 Dec; 280(6):584-594. PubMed ID: 27306880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Chromosome 18 in Neuroendocrine Tumors of the Small Intestine: The Enigma Remains.
    Nieser M; Henopp T; Brix J; Stoß L; Sitek B; Naboulsi W; Anlauf M; Schlitter AM; Klöppel G; Gress T; Moll R; Bartsch DK; Heverhagen AE; Knoefel WT; Kaemmerer D; Haybaeck J; Fend F; Sperveslage J; Sipos B
    Neuroendocrinology; 2017; 104(3):302-312. PubMed ID: 27222126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole genome sequencing reveals the independent clonal origin of multifocal ileal neuroendocrine tumors.
    Mäkinen N; Zhou M; Zhang Z; Kasai Y; Perez E; Kim GE; Thirlwell C; Nakakura E; Meyerson M
    Genome Med; 2022 Aug; 14(1):82. PubMed ID: 35922826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial small-intestine carcinoids: Chromosomal alterations and germline inositol polyphosphate multikinase sequencing.
    de Mestier L; Pasmant E; Fleury C; Brixi H; Sohier P; Féron T; Diebold MD; Clauser E; Cadiot G;
    Dig Liver Dis; 2017 Jan; 49(1):98-102. PubMed ID: 27825921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine.
    Elias E; Ardalan A; Lindberg M; Reinsbach SE; Muth A; Nilsson O; Arvidsson Y; Larsson E
    Nat Commun; 2021 Nov; 12(1):6367. PubMed ID: 34737276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome.
    Tonelli F; Giudici F; Giusti F; Marini F; Cianferotti L; Nesi G; Brandi ML
    Eur J Endocrinol; 2014 Aug; 171(2):K7-K17. PubMed ID: 24819502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEN4 and
    Alrezk R; Hannah-Shmouni F; Stratakis CA
    Endocr Relat Cancer; 2017 Oct; 24(10):T195-T208. PubMed ID: 28824003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
    Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
    Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiomic sequencing of paired primary and metastatic small bowel carcinoids.
    Postel MD; Darabi S; Howe JR; Liang WS; Craig DW; Demeure MJ
    F1000Res; 2023; 12():417. PubMed ID: 37954063
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential Protein Expression in Small Intestinal Neuroendocrine Tumors and Liver Metastases.
    Kim MK; Ye F; Wang D; Cui M; Ward SC; Warner RR; Roayaie S; Shafir M; Schwartz M; Zhang D; Itzkowitz S
    Pancreas; 2016 Apr; 45(4):528-32. PubMed ID: 26474427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A plausible role for actin gamma smooth muscle 2 (ACTG2) in small intestinal neuroendocrine tumorigenesis.
    Edfeldt K; Hellman P; Westin G; Stalberg P
    BMC Endocr Disord; 2016 Apr; 16():19. PubMed ID: 27107594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic alterations of CDKN1B are associated with small bowel neuroendocrine tumors.
    Maxwell JE; Sherman SK; Li G; Choi AB; Bellizzi AM; O'Dorisio TM; Howe JR
    Cancer Genet; 2015 Sep; ():. PubMed ID: 26603463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.